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Abstract
Background Glomerular filtration rate (GFR) is conventionally
indexed to body surface area (BSA), but this may lead to biased
results when applied to subjects of abnormal body size. The
aim of our study was to examine the impact of normalization to
the BSA and alternative body size descriptors on measured and
estimated GFR in overweight and obese children.
Methods This was a cross-sectional study of 313 children
aged 8–9 years old. GFR was measured by 24-h creatinine
clearance (CrCl) and additionally estimated from serum cre-
atinine and cystatin C (CysC) using the combined Zappitelli
formula, both as absolute values and adjusted to various body
size descriptors. The results were compared between 163 nor-
mal-weight, 89 overweight and 61 obese children.
Results Compared to the normal-weight children, mean abso-
lute GFR (both measured and estimated) was higher in the
overweight and obese children, whereas BSA-adjusted GFR
was lower. Linear regression models fitted in normal-weight
children revealed equally close associations between absolute
GFR and squared height, ideal body weight (IBW) and BSA
derived from IBW. Normalization of GFR to the IBW-derived
BSA completely eliminated the discrepancy between absolute
and BSA-indexed GFR in overweight and obese children.
Conclusions Indexing of GFR to BSA calculated from the
ideal—rather than actual—body weight is a promising ap-
proach to avoid overcorrection when studying obese children.
Further studies should assess the accuracy of this approach
across the full range of age and BMI distribution.
Liane Correia-Costa and Franz Schaefer contributed equally as first au-
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Introduction
The current epidemic of obesity is linked to the increase in
chronic kidney disease observed in adults over the past few
decades, and preliminary evidence suggests that the same ef-
fect may emerge in the pediatric population [1]. However,
there may be conceptual issues with normalizing glomerular
filtration rate (GFR) to body surface area (BSA) in obese
individuals. The rationale for indexing GFR to BSA is that
normal GFR is proportional to kidney size and the latter is
proportional to body size [2]. The BSA correction to
1.73 m2 was first proposed in 1928 [3] and became widely
used in clinical practice as it makes GFR values comparable
between adults and children [4]. However, the value of
1.73 m2 has become outdated due to the recent epidemic of
obesity [5]. Moreover, and more importantly, the scaling of
GFR to BSA in populations with a wide range of nutritional
status is highly controversial [6–8]. Since body mass index
(BMI) is strongly correlated with BSA, adjusting for BSA
removes any effect of bodyweight onGFR in epidemiological
studies including overweight and/or obese individuals [9].
While GFR adjustment to BSA has limited effects on calcu-
lated GFR in subjects with normal body size, an important
underestimation of true GFR appears to occur in subjects with
higher BMI [9, 10].
Since the number of nephrons is set at birth and does
not change with weight gain, an increase in GFR to
meet metabolic needs in the obese requires an increase
in single-nephron GFR which, according to the concept
of kidney symmorphosis, may represent a pathologic
rather than physiologic adaptive mechanism [2]. The un-
derestimation of GFR by BSA indexing might conceal
these changes [11, 12]. Some authors report that the use
of absolute values improves the performance of GFR
estimations in adults [13], while others propose that al-
ternative size descriptors should be used for indexing
[14–20]. It is probable that the same problems exist in
the children regarding the interpretation of BSA-adjusted
GFR levels [21]; in addition, the use of absolute GFR is
not an option when the target population of the analysis
is characterized by a wide age range. Few studies have
addressed this issue when comparing normal-weight
with overweight/obese children. Here, we utilize a large
sample of healthy normal-weight, overweight and obese
children to systematically study the impact of indexing
to various body size descriptors on measured and esti-
mated GFR.
Methods
Study design and sample
We conducted a cross-sectional study of children aged 8–
9 years followed since birth in a cohort study (Generation
XXI, Porto, Portugal) [22]. Subjects from the original cohort
were eligible for the present study protocol (ObiKid project) if
anthropometric data were available and a blood sample had
been withdrawn at the 7-year evaluation (n=4590), with the
exception that they fulfilled any one of the defined exclusion
criteria: (1) known presence of a genetic, renal or metabolic
disease (including diabetes mellitus); (2) use of medication
affecting arterial pressure or glucose or lipid metabolism; (3)
use of corticosteroid therapy, both inhaled or systemic, con-
tinuously or intermittently in the last 30 days; (4) albumin-to-
creatinine urinary ratio of >20 mg/mmol; (5) leukocyturia,
nitrituria and hematuria in urinalysis; (6) compliance to a spe-
cific diet, such as vegetarianism or use of protein supplements.
Our aim was to include a minimum sample of 300 children for
the Obikid project’s main objective. Assuming a 35% dropout
rate due to refusal to participate, exclusion criteria or incom-
plete information, 463 children were pre-selected to be con-
secutively screened according to the date of their 7-year eval-
uation. Of these 463 children, 16 could not be contacted, 32
refused to participate, 23 were unable to schedule the study
visits during the recruitment period and 68 met exclusion
criteria [4 chronic diseases (genetic, renal or metabolic); 1
chronic usage of medication (affecting blood pressure, glu-
cose or lipid metabolism), 51 living far from the study site;
12 twins]. Of the 324 enrolled participants, 11 were excluded
due to the lack of adequate blood or 24-h urine samples, leav-
ing 313 children for final analysis.
Data collection and variable definition
Anthropometric and general physical examinations were per-
formed according to standard procedures as previously report-
ed [23]. BMI-for-age values were classified into the following
categories using the World Health Organization reference da-
ta: normal weight [≤+1 standard deviation (SD)], overweight
(>1SD and≤+2SD) and obesity (>2SD) [24]. Classes of
gender-specific adequate birth weight for gestational age were
defined according to the 2013 revised Fenton growth refer-
ence curves [25].
Several body size descriptors were considered as possible
GFR adjusters. These were: (1) weight (in kg); (2) squared
height (in cm2); (3) BMI (in kg/m2) according to the standard
formula [weight (in kg) divided by squared height (in m)]; (4)
lean body mass (LBM, in kg) calculated by Peters equation
[26]; (5) fat-free mass (FFM) (in kg) evaluated by
bioimpedance analysis and calculated by Schaefer equation
[27]; (6) real BSA (in m2) calculated by the Haycock formula
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[28]; (7) ideal body weight (IBW in kg) inferred by a simple
calculation of weight, based on the 50th percentile of BMI-
for-age [IBW = BMI at 50th percentile (in kg/m2) multiplied
by squared height (in m)] [24, 29]; (8) BSA using IBW (in-
stead of child’s actual weight).
Laboratory procedures
Venous blood samples were collected after an overnight fast
and analyzed for creatinine and cystatin C (CysC). A 24-h
urine sample was collected from all participants for creatinine
analysis. The serum creatinine assay was based on the com-
pensated Jaffé method traceable to an isotope dilution mass
spectrometry method (Olympus AU 5400 analyzer;
Beckman-Coulter, Brea, CA) [30]. Urinary creatinine was
determined using the same clinical chemistry analyzer.
Serum CysC was assayed using a particle-enhanced
immunonephelometric assay (N latex CysC; Siemens,
Erlangen, Germany) before the implementation of the cer-
tified reference material (ERM-DA471/IFCC) [31].
Both the Zappitelli combined formula [32] and the
Schwartz combined formula [33] were used to estimate GFR
(in mL/min/1.73m2). Absolute GFR values were calculated by
multiplying the eGFR values by BSA and dividing by 1.73 m2.
The 24-h urine samples were considered valid if urinary creat-
inine was within the range of 11.3–28.0 mg/kg/day and if
urinary volume was >300 mL [34]. All children’s parents re-
ceived oral and written information on the correct methods of
collection and were asked to register the exact start and end
time of the collection; upon 24-h urine sample delivery at the
study site the parents were asked to complete a short question-
naire to recheck compliance with the protocol. We excluded 13
urine samples on the basis of inadequate urinary creatinine
excretion and two samples in which the collection was deemed
incomplete (urinary volume <300 mL and parents referring to
errors in the collection). The 24-h creatinine clearance (CrCl;
in mL/min;) was calculated in the remaining 298 cases accor-
ding to the standard formula; this was considered to be the
absolute CrCl. To obtain the value generally used in clinical
practice, i.e. normalized to 1.73 m2 of body surface (standard
CrCl; in mL/min/1.73 m2), the absolute CrCl was multiplied
by 1.73 and divided by the child’s BSA, as defined by the
Haycock formula [28]. To test alternative GFR adjusters by
the ratio method, absolute GFR/CrCl values were divided by
the value of each body size descriptor, thereby obtaining
different GFR values adjusted to several body size descriptors.
Statistical analysis
Statistical analysis was performed using the software program
SPSS Statistics for Windows, Version 20.0 (IBM Corp.,
Armonk, NY). Differences between BMI groups in continu-
ous variables were evaluated with one-way analysis of
variance, and those in categorical variables were evaluated
with the Chi-square test. Absolute CrCl was regressed on each
body size descriptor in separate linear regression models (ad-
ditionally adjusted for sex and age in months) in the normal
weight group in order to test whether the variations in the
indexed GFR were only due to differences in body size [19].
The fit of each model was evaluated by the respective R2
values (coefficients of determination). CrCl adjusted to BSA
using IBW (instead of the child’s real weight) was regressed
separately on weight, height and BMI z score to test the de-
pendence of this renal function estimation on body size. The
comparison of CrCl values adjusted to real BSA and BSA
using IBW, in normal weight, overweight and obese children,
was performed by a paired t test. Measures of association are
presented as beta coefficients with 95 % confidence intervals
(95 % CI). All p values are two-sided, and p<0.05 was con-
sidered statistically significant.
Results
A total of 313 children (53 % male) with a mean (SD) age of
8.8 (0.2) years were included in our analysis. The values of
body size descriptors and renal function markers (serum cre-
atinine and CysC) in normal-weight (n=163), overweight
(n=89) and obese (n=61) children are presented in Table 1.
The mean value of each body size descriptor considered was
higher in the overweight and obese groups, as were the serum
creatinine and CysC values. Compared to normal-weight chil-
dren, overweight and obese children were heavier at birth, but
no differences were found in the distribution of birth weight
adequacy for gestational age. Overweight and obese children
presented higher nighttime mean arterial pressure [74.7±5.1
and 75.4±6.4 mmHg, respectively, vs. 73.3±4.8 mmHg (nor-
mal-weight children); p<0.017] but similar daytime mean
arterial pressure [85.7±5.7 and 86.0±6.5 mmHg, respective-
ly, vs. 84.7±4.6 mmHg (normal-weight children); p<0.183].
No significant differences were found between the groups in
the percentage of children presenting a non-dipping pattern
(22, 33 and 29 % in normal-weight, overweight and obese
groups, respectively; p=0.143).
Compared to normal-weigth children, standard BSA-
adjusted eGFR values were lower in overweight and obese
children, and measured GFR was lower in obese children
(Table 2). By contrast, absolute measured and eGFR values
were significantly higher in overweight and obese children.
The GFR values adjusted to body size descriptors directly
dependent on body weight (weight, BMI and LBM) were
significantly lower in overweight and obese children.
Conversely, the GFR values adjusted to squared height,
FFM, IBW or IBW-derived BSAwere significantly higher in
overweight and obese children, in concordance with the re-
spective absolute GFR values (Table 2).
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To identify the body size descriptor that best reflects varia-
tion in kidney function with body size, we fitted separate linear
regression models, with absolute CrCl (mL/min) as the depen-
dent variable and each body size descriptor as the independent
variable, considering only normal-weight children. The
models incorporating squared height, IBW or IBW-derived
BSA had the highest coefficients of determination (R2), each
explaining about 15% of the absolute CrCl variation (Table 3).
Among these three variables, IBW-BSA adjustment is proba-
bly the most practical because (1) BSA adjustment is already
widely used in clinical practice and (2) adjustment to BSA
using IBW would only require a minor adaptation. The CrCl
adjusted to IBW-BSAwas independent of weight (β 1.14, 95
% CI −0.54 to 2.82; p=0.184), height (β 0.70, 95 % CI −0.34
to 1.73; p=0.186) and BMI z score (β 3.41, 95 % CI −3.98 to
10.80; p=0.363). Bland–Altman plots conveying the compa-
rison between the Schwartz and Zappitelli standard formulas
(BSA adjusted) and between each of these formulas adjusted to
BSA-IBW and the standard BSA-adjusted CrCl are presented
in Electronic Supplementary Material Figs. 1, 2 and 3 for nor-
mal-weight, overweight and obese children, respectively.
In our entire sample, no significant differences were found
between BSA-adjusted and IBW-BSA-adjusted CrCl values in
normal-weight children [162 (SD 34) vs. 162 (SD 34) mL/min/
1.73 m2, respectively; p=0.897]. However, BSA-adjusted
CrCl values were significantly lower than IBW-BSA-adjusted
CrCl values in both the overweight [152 (32) vs. 169 (34) mL/
min/1.73 m2, respectively; p<0.001] and obese [161 (26)
vs.196 (31) mL/min/1.73 m2, respectively; p<0.001) groups,
in accordance with absolute CrCl values (Table 2).
Discussion
The aim of our study was to evaluate the impact of GFR nor-
malization using different anthropometric descriptors of body
size in children of normal or increased body weight. We sub-
sequently identified important inconsistencies introduced by
GFR adjustment for body size in overweight and obese chil-
dren, with normalization to conventional BSA or other body
size descriptors dependent on weight yielding systematically
lower GFR estimates in these children than in normal-weight
children. Conversely, when GFR was expressed by absolute
values or those adjusted for height, IBWor IBW-derived BSA,
we obtained higher values of measured and estimated GFR for
the overweight and obese groups. Hence, the method of ad-
justment for body size is a major confounder of GFR determi-
nation in children with abnormal body habitus.
Although recognizing the lack of a solid reference standard
for GFR, we decided to use it as our reference standard, taking
Table 1 General characteristics
and body size descriptors in
normal-weight, overweight and
obese children
Patient characteristics Body weight categoriesa p
Normal weight Overweight Obese
Age (years) 8.8 (0.3) 8.8 (0.3) 8.8 (0.2) 0.452
Male sex 83 (51 %) 43 (48 %) 40 (66 %) 0.085
Body size descriptors
Weight (kg) 27.7 (3.3) 35.2 (3.6) 44.3 (6.7) <0.001
Height (cm) 131.1 (5.4) 134.4 (5.8) 137.5 (5.6) <0.001
BMI (kg/m2) 16.0 (1.2) 19.5 (0.9) 23.3 (2.3) <0.001
BMI z score −0.03 (0.74) 1.56 (0.30) 2.65 (0.48) <0.001
LBM, by Peters equation (kg) 23.9 (2.5) 28.4 (2.7) 33.4 (4.1) <0.001
FFM, by Schaefer equation (kg) 20.5 (2.0) 22.4 (2.5) 24.2 (2.1) <0.001
BSA, by Haycock equation (m2) 1.00 (0.08) 1.15 (0.08) 1.31 (0.12) <0.001
IBW (kg) 27.5 (2.3) 28.9 (2.6) 30.3 (2.5) <0.001
BSA-IBW (m2) 0.99 (0.06) 1.03 (0.07) 1.07 (0.07) <0.001
Renal function markers
Creatinine (mg/dL) 0.43 (0.06) 0.45 (0.06) 0.45 (0.06) 0.003
Cystatin C (mg/L) 0.64 (0.07) 0.67 (0.08) 0.68 (0.06) <0.001
Values in table are presented as the mean, with the standard deviation (SD) in parenthesis or as a number with the
percentage in parenthesis, as appropriate
BMI, Body mass index; LBM, lean body mass (estimated by Peters’ equation) [26]; FFM, fat-free mass (esti-
mated by Schaefer’s equation) [27]; BSA, body surface area (calculated by the Haycock equation [28]); IBW,
ideal body weight; BSA-IBW, body surface area calculated by Haycock equation, using IBW instead of child’s
real weight
a The normal weight, overweight and obese groups were defined according to the World Health Organization
classification for BMI z score [24]
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care to include only correctly timed 24-h collections. The
finding of an increased absolute GFR in both the overweight
and obese children is consistent with the notion of glomerular
hyperfiltration as the initial stage of obesity-associated renal
dysfunction [35, 36]. It should be noted that the higher levels
of creatinine and CysC found in our overweight/obese chil-
dren may result from these children being slightly taller and
possibly thereby presenting higher levels of muscle mass or
body fat mass [37, 38], both of which are known to interfere
with each one of the markers used. Analysis of unadjusted
GFR in pediatric studies is only possible if the population of
interest is limited to a narrow range of body size, as in this
assessment of 8- to 9-year-old children. Studies encompassing
a wider age range mandate either the use of percentiles, as
proposed by Piepsz et al. [39], or adjustment of GFR for some
measure of body size. Since pediatric percentiles of absolute
GFR are currently not available for any methodology of GFR
measurement other than the largely abandoned radioactive
51Cr-EDTA clearance method, we considered it to be more
useful to identify an alternative body size descriptor to replace
BSA to normalize both measured and estimated GFR. For that
purpose we compared the association between several body
size descriptors and absolute CrCl in order to identify the
variables most closely related to variations in GFR. This part
of the analysis was restricted to normal-weight children to rule
out any potential obesity-related bias. Squared height, IBW
and IBW-based BSAwere found to be equally closely corre-
lated to absolute GFR. In fact, these are all anthropometric
Table 2 Absolute and adjusted estimates of glomerular filtration rate in normal-weight, overweight and obese children
Estimates of GFRa Body weight categories p
Normal weight Overweight Obese
Absolute CrCl (mL/min) 93.2 (21.0) 101.4 (21.4) 120.8 (21.5) <0.001
Absolute GFR, by Zappitelli formula (mL/min) 79.8 (10.5) 87.8 (11.6) 100.1 (14.4) <0.001
Absolute GFR, by Schwartz formula (mL/min) 65.1 (8.3) 73.1 (9.1) 83.2 (12.5) <0.001
Weight-adjusted CrCl (mL/min/kg) 3.4 (0.7) 2.9 (0.6) 2.8 (0.5) <0.001
Weight-adjusted GFR, by Zappitelli formula (mL/min/kg) 2.9 (0.4) 2.5 (0.3) 2.3 (0.2) <0.001
Weight-adjusted GFR, by Schwartz formula (mL/min/kg) 2.4 (0.3) 2.1 (0.2) 1.9 (0.2) <0.001
Squared height-adjusted CrCl (mL/min/cm2) 54.3 (11.4) 55.9 (11.4) 64.0 (10.0) <0.001
Squared height-adjusted GFR, by Zappitelli formula (mL/min/cm2) 46.4 (5.4) 48.6 (5.9) 52.8 (5.9) <0.001
Squared height-adjusted GFR, by Schwartz formula (mL/min/cm2) 37.8 (3.9) 40.5 (4.1) 43.8 (5.0) <0.001
BMI-adjusted CrCl (mL/min/kg/m2) 5.8 (1.4) 5.2 (1.2) 5.2 (1.0) <0.001
BMI-adjusted GFR, by Zappitelli formula (mL/min/kg/m2) 5.0 (0.7) 4.5 (0.6) 4.3 (0.5) <0.001
BMI-adjusted GFR, by Schwartz formula (mL/min/kg/m2) 4.1 (0.5) 3.8 (0.5) 3.6 (0.4) <0.001
LBM-adjusted CrCl (mL/min/kg) 3.9 (0.8) 3.6 (0.7) 3.7 (0.6) 0.001
LBM-adjusted GFR, by Zappitelli formula (mL/min/kg) 3.4 (0.4) 3.1 (0.4) 3.0 (0.3) <0.001
LBM-adjusted GFR, by Schwartz formula (mL/min/kg) 2.7 (0.3) 2.6 (0.3) 2.5 (0.2) <0.001
FFM-adjusted CrCl (mL/min/kg) 4.6 (1.0) 4.6 (1.1) 5.0 (0.9) 0.012
FFM-adjusted GFR, by Zappitelli formula (mL/min/kg) 3.9 (0. 6) 4.0 (0.7) 4.1 (0.6) 0.037
FFM-adjusted GFR, by Schwartz formula (mL/min/kg) 3.2 (0.5) 3.3 (0.5) 3.4 (0.5) 0.002
IBW-adjusted CrCl (mL/min/kg) 3.4 (0.7) 3.5 (0.7) 4.0 (0.6) <0.001
IBW-adjusted GFR, by Zappitelli formula (mL/min/kg) 2.9 (0.3) 3.0 (0.4) 3.3 (0.4) <0.001
IBW-adjusted GFR, by Schwartz formula (mL/min/kg) 2.4 (0.2) 2.5 (0.3) 2.7 (0.3) <0.001
BSA-IBW-adjusted CrCl (mL/min/1.73 m2) 161.9 (34.3) 169.2 (34.1) 195.6 (30.9) <0.001
BSA-IBW-adjusted GFR, by Zappitelli formula (mL/min/1.73 m2) 138.6 (16.0) 146.9 (17.3) 161.6 (18.5) <0.001
BSA-IBW adjusted GFR, by Schwartz formula (mL/min/1.73 m2) 112.9 (11.7) 122.3 (12.3) 134.2 (15.9) <0.001
Standard CrCl (BSA adjusted) (mL/min/1.73 m2) 162.0 (34.4) 152.4 (31.5) 160.7 (26.3) 0.077
Standard GFR (BSA adjusted), by Zappitelli formula (mL/min/1.73 m2) 138.5 (15.7) 132.3 (16.2) 132.1 (13.0) 0.002
Standard GFR (BSA adjusted), by Schwartz formula (mL/min/1.73 m2) 112.7 (11.2) 110.1 (11.1) 109.6 (10.4) 0.069
Values in table are presented as the mean with the SD in parenthesis
GFR, Glomerular filtration rate; CrCl, 24-h creatinine clearance. See Table 1 footnote for all other abbreviations
a Absolute GFR values were derived from the Zappitelli or Schwartz combined formulas by multiplying the standard GFR values by the children’s BSA
and dividing by 1.73m2 . Adjusted GFR values for each size descriptor were obtained by dividing the absolute GFR by the value of the size descriptor of
each child
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indicators that reflect body size independently of adiposity.
We propose that IBW-BSA be used to normalize GFR in
obese children, as this approach will still allow comparisons
with the standard GFR values used in clinical practice.
The impact of using IBW rather than actual weight to cal-
culate BSA in obese children is evident both from the applica-
tion of the normalization method to the whole study sample
and from the use of a practical example. Let us consider two 9-
year-old boys of the same height but different body weight
whom we assume have the same renal function (absolute
CrCl80 mL/min). The normal-weight boy has similar values
of BSA derived from his actual and IBW and, therefore, pre-
sents a minimal difference in the respective adjusted CrCl
values. In the obese boy, actual BSA is 1.30 m2 whereas the
IBW-derived BSA equals that of the normal-weight boy,
resulting in a difference in adjusted CrCl of about 20 mL/
min/1.73 m2 (CrCl adjusted to BSA: 106.5 mL/min/1.73 m2
vs. CrCl adjusted to BSA-IBW: 127.0mL/min/1.73 m2). Thus,
equivalent to the findings with uncorrected GFR, IBW-BSA
adjusted GFR is increased in overweight and obese children.
The use of IBW-derived BSA for GFR normalization has
been postulated previously [8] and recently also found to
avoid overcorrection in obese adults [40]. Another study in
adults, aimed at determining the influence of GFR on drug
clearance, also found that the use of IBW in a GFR formula
including body weight increased the probability of achieving
effective therapeutic exposure [41]. In children, the usefulness
of calculating BSA from IBW has been recognized in other
clinical settings, such as indexing ventricular mass, after ac-
knowledging that the standardmethod using actual BSA led to
underestimation of the volume load in obese patients [42].
Another study in adults identified total body water as the best
adjuster and proposed that a standardized value of total body
water should replace the current practice of normalizing GFR
to 1.73 m2 BSA [18]. However, in clinical practice total body
water is estimated by anthropometric equations incorporating
weight and would therefore be likely to cause the same over-
correction as BSAwhen applied in obese individuals [39].
The large sample size of healthy children across all BMI
classes can be considered to be a major strength of this study,
as is the high methodological standardization of 24-h collec-
tion and the use of an equation for GFR estimation combining
CysC and creatinine. The use of an endogenous clearance
technique to measure GFR represents a limitation since this
method is known to overestimate GFR by at least 10 % be-
cause of active creatinine excretion by the renal tubules [43,
44]. Evaluation of the accuracy of equations on GFR estima-
tion when compared to CrCl in this group of children was
performed in a previous study of our group [45]. Other impor-
tant limitations of our study are the restriction of the analysis
to a single pediatric age group and the fact that BSA was
estimated and not directly measured. We intend to confirm
our findings in future studies using exogenous GFR measure-
ments in children with a wider range of age and also with
chronic kidney disease, thereby extending the ability to gen-
eralize our conclusions.
In light of our results and those from the relevant literature,
we believe that alternative ways to index GFR need to be
considered in the setting of pediatric obesity.While assessment
of absolute GFR without any indexation may represent an
appropriate approach in cohorts with substantial variation of
fat mass and is suitable for intra-individual longitudinal analy-
ses, it does not allow comparisons with reference values and
with children across the pediatric age range. Normalization of
GFR to BSA calculated from IBW rather than actual weight is
a promising option that deserves further investigation across all
pediatric age groups, ideally in healthy children.
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Table 3 Influence of several
body size descriptors on absolute
24-h creatinine clearance in nor-
mal weight children
Absolute CrCl (mL/min) Intercept (95 % CI) β (95 % CI) R2
Weight (kg) 110.56 (−3.27 to 224.39) 1.909 (0.920 to 2.899)** 0.111
Squared height (cm2) 64.22 (−48.52 to 176.95) 0.005 (0.003 to 0.008)** 0.149
BMI (kg/m2) 94.81 (−25.66 to 215.29) 1.539 (−1.219 to 4.297) 0.033
LBM, by Peters equation (kg) 104.61 (−7.66 to 216.88) 3.280 (1.796 to 4.763)** 0.135
FFM, by Schaefer equation (kg) 53.68 (−71.29 to 178.65) 2.406 (0.622 to 4.189)* 0.071
BSA, by Haycock equation (m2) 78.40 (−35.13 to 191.93) 88.653 (46.862 to 130.444)** 0.127
IBW (kg) 82.83 (−29.11 to 194.78) 3.342 (1.915 to 4.769)** 0.147
BSA-IBW (m2) 44.44 (−70.01 to 158.89) 125.871 (72.486 to 179.257)** 0.148
*p < 0.050; **p value < 0.001
Each row represents a separate multiple linear regression of the absolute 24-h CrCl on the corresponding inde-
pendent variable. All analyses were adjusted for sex and age. The regression coefficients are given per unit
95 % CI, 95 % Confidence interval. See footnotes to Tables 1 and 2 all other abbreviations
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